{
    "cancelStatus": "0",
    "licStatus": "1",
    "cancelDate": null,
    "cancelReason": [],
    "otherCancelReason": "",
    "licid": "52027838",
    "licUnit": "1",
    "validDate": "2025-03-17 00:00:00.000",
    "issueDate": "2020-03-17 00:00:00.000",
    "oriIssueDate": "2020-03-17",
    "licKind": "10",
    "oldLicid": null,
    "certNo": "DHA05202783802",
    "prodNameC": "依托考昔",
    "prodNameE": "Etoricoxib",
    "indicationsName": [
        "消炎止痛"
    ],
    "does": "0040",
    "packageUnit": [
        {
            "packageSpec": "",
            "packageUnit": "4C"
        }
    ],
    "medMCode": "01",
    "maMedCode": "",
    "medDCode": "E",
    "mainCategory": "E",
    "drBaseId": "04EBF9D5-6D7E-476B-93C3-773DE3F52358",
    "subCategory": [],
    "ingredientsDesc": [
        "Etoricoxib contains NLT 98.0% and NMT 102.0% of Etoricoxib (C18H15ClN2O2S) per mg, calculated on the anhydrous basis."
    ],
    "restraintItemsCode": [
        "02 輸 入"
    ],
    "applicantName": "中大藥品股份有限公司",
    "applicantAddr": "台南市中西區民權路二段158號3樓",
    "medClass": null,
    "efficacy": " ",
    "mdFormat": null,
    "productAnnotation": "",
    "mdKind": [],
    "monitorDate": null,
    "licidNew": null,
    "licidOld": null,
    "factoryDtoList": [
        {
            "id": "3E57D73E-FCCA-4094-A45E-1E39A3DE2408",
            "factoryCode": "1",
            "factoryName": "Hetero Labs Limited (Unit-I)",
            "factoryAddr": "Survey No.10,I.D.A.,Gaddapotharam Village, Jinnaram Mandal, Sangareddy District, Telangana State, India.",
            "factoryCompanyAddr": null,
            "countryCode": "IN",
            "processCode": [],
            "processCodeStr": null,
            "factoryKind": "M",
            "factoryNo": "FIN0526200",
            "factoryInfo": null,
            "qsd": null,
            "qsdList": [],
            "factoryMadeIn": null
        }
    ],
    "ingredientsDtoList": [
        {
            "ingredientsKind": "1",
            "ingredientsCode": null,
            "ingredientsName": "Etoricoxib contains NLT 98.0% and NMT 102.0% of Etoricoxib (C18H15ClN2O2S) per mg, calculated on the anhydrous basis.",
            "ingredientsDesc": "Etoricoxib contains NLT 98.0% and NMT 102.0% of Etoricoxib (C18H15ClN2O2S) per mg, calculated on the anhydrous basis.",
            "concentDesc": null,
            "concent": null,
            "concentUnit": null,
            "seq": "1",
            "prescription_seq": "1",
            "prescription_Kind": "2"
        }
    ],
    "authDtoList": [],
    "iomDtoList": [],
    "changeDtoList": [],
    "atcList": [
        {
            "isMain": "1",
            "atcCode": "M01AH05"
        }
    ],
    "licBaseId": "F7882551-8C38-435E-B2CB-77646B153875"
}